Expanding Buprenorphine Administration by Healthcare Providers
This proposed bill would allow additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone. It also clarifies that prescribing a buprenorphine product to nursing mothers or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for treating opioid use disorder without naloxone. This change affects healthcare providers and patients receiving treatment for opioid use disorder in Tennessee.
Previously, only certain healthcare providers were authorized to administer buprenorphine for opioid use disorder treatment.
This proposed bill would allow additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone. It also clarifies that prescribing a buprenorphine product to nursing mothers or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for treating opioid use disorder without naloxone. This change affects healthcare providers and patients receiving treatment for opioid use disorder in Tennessee.